BQGE:F:F-Ossiam Lux Barclays Quantic Global E NR (EUR)

ETF | Others |

Last Closing

USD 128.58

Change

+0.22 (+0.17)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.75%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.67%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.46 (-0.81%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.00 (-0.82%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

+0.05 (+0.05%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.29 (+0.26%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.32%)

USD 38.52B
0ZC:F Zscaler Inc

-0.36 (-0.20%)

USD 37.92B

ETFs Containing BQGE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.94% 57% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.94% 57% F 53% F
Trailing 12 Months  
Capital Gain 15.88% 67% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.88% 64% D 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.07% 63% D 61% D-
Dividend Return 8.07% 60% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.87% 72% C 92% A
Risk Adjusted Return 90.97% 88% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike